[How AMOG limits the supply of diabetes drugs].
, .
Elke
E
Oberhofer
D017046:Cost Savings / Q000331:legislation & jurisprudence; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000191:economics*; D017277:Drug Approval / Q000191:economics* / Q000331:legislation & jurisprudence*; D016527:Drug Costs / Q000331:legislation & jurisprudence; D057915:Drug Substitution / Q000191:economics; D005858:Germany; D018166:Health Care Reform / Q000191:economics* / Q000331:legislation & jurisprudence*; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000600:supply & distribution*; D009313:National Health Programs / Q000191:economics* / Q000331:legislation & jurisprudence*
D007004:Hypoglycemic Agents